{
    "ticker": "TEVA",
    "name": "Teva Pharmaceutical Industries Limited",
    "description": "Teva Pharmaceutical Industries Limited is a global leader in the pharmaceutical industry, specializing in generic and specialty medications. Founded in 1901 and headquartered in Petah Tikva, Israel, Teva is dedicated to improving the health and quality of life of patients around the world through innovative and accessible healthcare solutions. The company produces a wide range of generic medications, which are essential for reducing healthcare costs and increasing access to vital treatments. Teva is also a major player in the development of specialty drugs, particularly in the areas of neurology, pain management, and respiratory health. Their flagship product, Copaxone, is a leading treatment for multiple sclerosis. Teva has a strong commitment to sustainability and corporate responsibility, focusing on ethical practices and the well-being of patients, employees, and the community. With a robust pipeline of new therapies and a significant global presence, Teva continues to advance healthcare and address the growing challenges of the pharmaceutical industry.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Petah Tikva, Israel",
    "founded": "1901",
    "website": "https://www.tevapharm.com",
    "ceo": "K\u00e5re Schultz",
    "social_media": {
        "twitter": "https://twitter.com/TevaPharm",
        "linkedin": "https://www.linkedin.com/company/teva-pharmaceutical-industries-limited"
    },
    "investor_relations": "https://ir.tevapharm.com",
    "key_executives": [
        {
            "name": "K\u00e5re Schultz",
            "position": "CEO"
        },
        {
            "name": "Eli Kalif",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Generic Medications",
            "products": [
                "Antibiotics",
                "Cardiovascular Drugs",
                "Pain Management"
            ]
        },
        {
            "category": "Specialty Medications",
            "products": [
                "Copaxone",
                "Ajovy",
                "Proair HFA"
            ]
        }
    ],
    "seo": {
        "meta_title": "Teva Pharmaceutical Industries Limited | Global Leader in Pharmaceuticals",
        "meta_description": "Explore Teva Pharmaceutical Industries Limited, a leader in generic and specialty medications dedicated to improving global health. Discover our products, mission, and impact.",
        "keywords": [
            "Teva",
            "Pharmaceuticals",
            "Generic Medications",
            "Specialty Medications",
            "Healthcare",
            "Copaxone"
        ]
    },
    "faq": [
        {
            "question": "What is Teva known for?",
            "answer": "Teva is known for its wide range of generic and specialty medications, including treatments for multiple sclerosis."
        },
        {
            "question": "Who is the CEO of Teva?",
            "answer": "K\u00e5re Schultz is the CEO of Teva Pharmaceutical Industries Limited."
        },
        {
            "question": "Where is Teva headquartered?",
            "answer": "Teva is headquartered in Petah Tikva, Israel."
        },
        {
            "question": "What are Teva's main products?",
            "answer": "Teva's main products include a variety of generic medications and specialty drugs like Copaxone."
        },
        {
            "question": "When was Teva founded?",
            "answer": "Teva was founded in 1901."
        }
    ],
    "competitors": [
        "PFE",
        "BMY",
        "MRK",
        "JNJ"
    ],
    "related_stocks": [
        "ABBV",
        "AMGN",
        "GILD",
        "NVS"
    ]
}